Clinical Trials Browser

Interventional × Inhalation × 90 days × Clear all

NCT07558538 2026-04-30

Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Follicular, Acute Lung Injury

NCT04481035 2026-04-21

NF1NAC

Phase 2 Completed

5 enrolled 10 charts

Neurofibromatosis 1